Regeneron Pharmaceuticals
REGNUS ListedRegeneron Pharmaceuticals (REGN) is a leading publicly traded corporation listed in the United States, constituent of the S&P 500 and NASDAQ-100 index.
Stock Snapshot & Key Numbers — Regeneron Pharmaceuticals
Verified Daily CloseOfficial closing price, 1-year price range, valuation multiples, and market value from exchange records.
Regeneron Pharmaceuticals (REGN) is a US equity security listed on the NASDAQ. As of the last recorded market session on Close on 16 Oct 2026, the stock closed at $790.74, recording a -5.60 (-0.70%) decline from its previous close of $796.34. Over the trailing 52-week trading cycle, REGN has traded between a 52-week low of $569.17 and a 52-week high of $852.03, establishing its annual trading channel. In historical performance, Regeneron Pharmaceuticals has gained 38.93% over the past 1 year. Period returns across standard measurement intervals include: 1-week: +5.92%, 1-month: +2.08%, 6-month: +6%, 1-year: +38.93%, 3-year: -6.27%, 5-year: +45.5%. Daily reported trading volume reached 653,500 equity shares. On key valuation multiples as of Oct 13, 2026, the company trades at a trailing price-to-earnings (P/E) multiple of 18.9x and a price-to-book (P/B) ratio of 2.4x, with a trailing dividend yield of 0.50%. Its market capitalization stands at $78.54B. The company is categorized under the Health Care sector and S&P 500 & NASDAQ-100 industry within the US equities universe.
Price Chart
Trading Multiples & Ranges
Price boundaries and liquidity distribution.
Past Price Win/Loss Odds (1-Week, 1-Month, 3-Month)
How often this stock rose, stayed flat, or fell over past 21-day holding periods (based on historical data, not a future prediction).
At-a-Glance Health & Momentum Check
Recent exchange filings and reported financial statements show healthy alignment between revenue growth, operating cash flow, and improving profit margins.
How Outside Factors Affect This Stock (Market, Crude Oil & Currency)
How closely this stock moved with the broader market index, crude oil, and the exchange rate over the past year.
| Factor / Benchmark | 1Y Beta (Sensitivity) | 1Y Correlation (-1 to +1) | What This Means |
|---|---|---|---|
| S&P 500 | +0.50 | +0.20 | Trailing 1Y historical sensitivity: a 1% move in S&P 500 coincided with a +0.50% co-movement (correlation: 0.20). Descriptive historical relationship, not predictive. |
| US 10Y Treasury Yield | -0.55 | -0.24 | Trailing 1Y historical sensitivity: a 1% move in US 10Y Treasury Yield coincided with a -0.55% co-movement (correlation: -0.24). Descriptive historical relationship, not predictive. |
| Brent Crude Oil | -0.11 | -0.18 | Trailing 1Y historical sensitivity: a 1% move in Brent Crude Oil coincided with a -0.11% co-movement (correlation: -0.18). Descriptive historical relationship, not predictive. |
| USD / INR | +0.16 | +0.04 | Trailing 1Y historical sensitivity: a 1% move in USD / INR coincided with a +0.16% co-movement (correlation: 0.04). Descriptive historical relationship, not predictive. |
How to read Beta & Correlation ( Beta > 1 = wider swings than market; < 1 = calmer )▾
Sensitivities measure historical 1-year regression beta and correlation across paired daily trading sessions over the past 252 trading days. Past relationships can shift over time and do not guarantee future co-movement.
Trailing Returns Breakdown
Calendar-aligned historical percentage performance across standard market windows.
| Period | Start Price | Current Price | Return (%) |
|---|---|---|---|
| 1 Week | ₹746.54 | ₹790.74 | +5.92% |
| 15 Days | ₹734.81 | ₹790.74 | +7.61% |
| 1 Month | ₹774.61 | ₹790.74 | +2.08% |
| 3 Months | ₹678.94 | ₹790.74 | +16.47% |
| 6 Months | ₹746.00 | ₹790.74 | +6.00% |
| 1 Year | ₹569.17 | ₹790.74 | +38.93% |
| 3 Years | ₹843.66 | ₹790.74 | -6.27% |
| 5 Years | ₹543.48 | ₹790.74 | +45.50% |
Price Swings & Biggest Historical Drops
How much this stock typically fluctuates and its largest peak-to-bottom drops over 1 and 5 years.
Calendar-Year Historical Performance
Annual performance breakdown comparing first and last closing sessions of each calendar year.
| Calendar Year | Start Close | End Close | Annual Return | Trajectory Bar |
|---|---|---|---|---|
| CY 2026 | ₹776.31 | ₹790.74 | +1.9% | |
| CY 2025 | ₹715.19 | ₹771.87 | +7.9% | |
| CY 2024 | ₹905.00 | ₹712.33 | -21.3% | |
| CY 2023 | ₹720.47 | ₹878.29 | +21.9% | |
| CY 2022 | ₹627.10 | ₹721.49 | +15.1% | |
| CY 2021 | ₹543.48 | ₹631.52 | +16.2% |
Corporate Actions History
No dividend or stock split distributions recorded in historical feeds for REGN.
Historical Investment Simulator
Factual simulation of past returns in Regeneron Pharmaceuticals (REGN) using real recorded closing prices.
Recent News & Official Exchange Announcements
Official exchange filings, order wins, and company updates. Click any announcement to see how it affects the business on the right.
Regeneron Pharmaceuticals stock consolidates as Global Capability Centre opening in Hyderabad draws focus - Traders Union
Regeneron Pharmaceuticals stock consolidates as Global Capability Centre opening in Hyderabad draws focus Traders Union
Why This Matters for the Business
Plain-English breakdown of how the selected announcement connects to revenue, costs, and business drivers.
Institutional regulatory disclosure or industry observation
- •Verified against public financial wire feeds and exchange disclosures
Volume throughput absorbs fixed manufacturing plant overheads, supporting operating EBITDA margins and cash generation across health care units.
Continuous commercial tenders and capital expenditures lock in forward order book-to-bill expansion.
Common Questions About Regeneron Pharmaceuticals (REGN)
Key facts on REGN share price, historical returns, valuation ratios, and past SIP performance.
What is the current share price and 52-week range of Regeneron Pharmaceuticals (REGN)?
As of 16 Oct 2026, the official closing share price of Regeneron Pharmaceuticals (REGN) on NASDAQ is $790.74 (-0.70% vs the previous close). Over the past 52 weeks, REGN has traded between a low of $569.17 and a high of $852.03, with a reported market capitalization of $78.54B.
What are the historical returns of Regeneron Pharmaceuticals (REGN)?
Based on split-adjusted closing prices through 16 Oct 2026, Regeneron Pharmaceuticals (REGN) recorded the following trailing price returns: 1 Week: +5.92% (from $746.54 to $790.74); 15 Days: +7.61% (from $734.81 to $790.74); 1 Month: +2.08% (from $774.61 to $790.74); 3 Months: +16.47% (from $678.94 to $790.74); 6 Months: +6.00% (from $746.00 to $790.74); 1 Year: +38.93% (from $569.17 to $790.74); 3 Years: -6.27% (from $843.66 to $790.74); 5 Years: +45.50% (from $543.48 to $790.74). Past performance reflects historical exchange records and does not predict future returns.
What is the P/E ratio, P/B ratio, and dividend yield of Regeneron Pharmaceuticals (REGN)?
Regeneron Pharmaceuticals (REGN) currently trades at a trailing Price-to-Earnings (P/E) ratio of 18.9x, a Price-to-Book (P/B) ratio of 2.4x, and a trailing 12-month dividend yield of 0.50%. It operates in the Health Care sector (S&P 500 & NASDAQ-100).
How much would a past lump-sum or monthly SIP investment in REGN have grown?
Based on historical closing prices for Regeneron Pharmaceuticals (REGN): A one-time lump-sum investment of $10000.00 held for 5 years would be worth $14549.57 (+45.5% total return, 7.8% CAGR), while a monthly SIP of $500.00 over 5 years (total invested: $30500.00) would be worth $33525.23 (+9.9% absolute return). You can test custom amounts and holding periods in the interactive calculator above.